Peng Zhang

3PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 05, 2026
Integrative Omics Analysis Reveals the Potential Value of CEACAM6 in Pan-Gastrointestinal Cancers.

Liying Jin, Changjuan Tao, Zhiyong Pan

|Jun 14, 2024
Epigenetic Reprogramming Potentiates ICAM1 Antibody Drug Conjugates in Preclinical Models of Melanoma.

Peng Zhang, Changjuan Tao, Ye Lu

|Aug 31, 2022
Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study.

Lili Mao, Meiyu Fang, Yu Chen

Pageof 1